Follow
Anna Puła
Anna Puła
Medical University of Lodz
Verified email at stud.umed.lodz.pl
Title
Cited by
Cited by
Year
Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized …
A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak
Leukemia & Lymphoma 59 (5), 1084-1094, 2018
192018
Patients’ awareness of the prevention and treatment of colorectal cancer
Ł Dziki, A Puła, K Stawiski, B Mudza, M Włodarczyk, A Dziki
Polish Journal of Surgery 87 (9), 459-463, 2015
142015
Chemotherapy delays in children with acute lymphoblastic leukemia might influence the outcome of treatment
A Puła, M Zdunek, K Michalczyk, M Cichosz, W Młynarski
Acta Haematologica Polonica 53 (2), 141-148, 2022
112022
MicroRNA in multiple myeloma-a role in pathogenesis and prognostic significance
A Puła, P Robak, T Robak
Current Medicinal Chemistry 28 (33), 6753-6772, 2021
72021
Hairy cell leukemia: a brief update on current knowledge and treatment prospects
A Puła, T Robak
Current Opinion in Oncology 33 (5), 412-419, 2021
62021
The significance of mRNA in the biology of multiple myeloma and its clinical implications
A Puła, P Robak, D Mikulski, T Robak
International journal of molecular sciences 22 (21), 12070, 2021
32021
PancreApp: An Innovative Approach to Computational Individualization of Nutritional Therapy in Chronic Gastrointestinal Disorders.
K Stawiski, A Strzalka, A Pula, K Bijakowski
MedInfo, 325-328, 2015
22015
Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens–pilot study
A Puła, T Robak, I Dróżdż, K Stawiski, A Rycerz, M Misiewicz, P Robak
Leukemia & Lymphoma 65 (2), 257-264, 2024
12024
P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS.
A Puła, P Robak, D Jarych, D Mikulski, I Dróżdż, J Szemraj, T Robak
HemaSphere 6, 761-762, 2022
12022
The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
A Puła, P Robak, D Jarych, D Mikulski, M Misiewicz, I Drozdz, W Fendler, ...
International Journal of Molecular Sciences 24 (3), 2938, 2023
2023
SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA
D Dytfeld, J Radocha, R Hajek, G Cengiz-Seval, M Berkac, D Coriu, ...
Acta Haematologica Polonica 54 (2), 82-85, 2023
2023
A Circulating Serum miRNA-Based Model to Predict Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
A Puła, P Robak, D Jarych, D Mikulski, M Misiewicz, I Drozdz, W Fendler, ...
Preprints, 2022
2022
A systematic review and meta-analysis of B-cell receptor signaling inhibitors in relapsed and refractory chronic lymphocytic leukemia
A Pula, K Stawiski, M Braun, E Iskierka-Jazdzewska, T Robak
LEUKEMIA & LYMPHOMA 58, 152-153, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–13